Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.

@article{Rallidis2016PrevalenceOH,
  title={Prevalence of heterozygous familial hypercholesterolaemia and its impact on long-term prognosis in patients with very early ST-segment elevation myocardial infarction in the era of statins.},
  author={Loukianos S Rallidis and Andreas S Triantafyllis and Georgios Tsirebolos and Dimitrios Katsaras and Maria Rallidi and Paraskevi C Moutsatsou and Jonh Lekakis},
  journal={Atherosclerosis},
  year={2016},
  volume={249},
  pages={17-21}
}
BACKGROUND AND AIMS Familial hypercholesterolaemia (FH) is an important cause of early onset coronary artery disease. We assessed the prevalence of clinical heterozygous FH (HeFH) among patients with very early ST-segment elevation myocardial infarction (STEMI), its management and its impact on long-term prognosis in the era of widespread utilization of statins. METHODS We recruited prospectively 320 consecutive patients who had survived their first STEMI ≤35 years of age. Using the Dutch… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 5 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Similar Papers

Loading similar papers…